Last 12 months
Inside the activity.
0 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 25, 2023 Filed Aug 28, 2023 17:29 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 1,266 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017146 · form4.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 430,159 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 17:29 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,032 | $381.78 | $393,996.96 |
DisclosureSEC source: 0001062993-23-017146 · form4.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 428,893 Read SEC document |
| August 25, 2023 Filed Aug 28, 2023 17:29 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,081 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-017146 · form4.xml · nonDerivative · entry 1 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 429,925 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| August 23, 2023 Filed Aug 23, 2023 23:42 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
SaleBio-Rad A Common Stock | 300 | $384.69 | $115,407.00 |
DisclosureSEC source: 0001062993-23-017040 · form4.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,415.7965 F1 · balance_after: Includes 19.319 and 25.114 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 3/31/2023 and 06/30/2023, respectively. Read SEC document |
| June 15, 2023 Filed Jun 16, 2023 18:02 UTC |
Crowley MichaelEVP, GBL Commercial Operations
|
SaleBio-Rad A Common Stock | 500 | $379.39 | $189,695.00 |
DisclosureSEC source: 0001062993-23-013732 · form4.xml · nonDerivative · entry 1 Crowley Michael · CIK 0001629381 · EVP, GBL Commercial Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,040 Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 15:31 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
SaleBio-Rad A Common Stock | 181 | $368.28 | $66,658.68 |
DisclosureSEC source: 0001062993-23-013074 · form4.xml · nonDerivative · entry 2 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Read SEC document |
| June 06, 2023 Filed Jun 7, 2023 15:31 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
SaleBio-Rad A Common Stock | 17.352 | $368.49 | $6,394.04 |
DisclosureSEC source: 0001062993-23-013074 · form4.xml · nonDerivative · entry 1 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 181 Read SEC document |
| May 03, 2023 Filed May 1, 2024 15:52 UTC |
SCHWARTZ STEVEN D10% owner
|
SaleBio-Rad A Common Stock | 320 | $463.86 | $148,435.20 |
DisclosureSEC source: 0001062993-24-009134 · form4.xml · nonDerivative · entry 1 SCHWARTZ STEVEN D · CIK 0000940804 · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · By Spouse Disclosed balance after: 1,498.0335 F1 · balance_after: Total reflects the number of shares beneficially owned by the insider as of the date of the report. F2 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| April 29, 2023 Filed May 1, 2023 16:51 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 1,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009749 · form4.xml · derivative · entry 3 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Underlying: Bio-Rad A Common Stock · 1,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 29, 2019, the reporting person was granted 5,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 29, 2023 Filed May 1, 2023 16:51 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Tax withholdingBio-Rad A Common Stock | 346 | $450.79 | $155,973.34 |
DisclosureSEC source: 0001062993-23-009749 · form4.xml · nonDerivative · entry 2 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,766.6151 Read SEC document |
| April 29, 2023 Filed May 1, 2023 16:51 UTC |
Last Andrew J.EVP, Chief Operating Officer
|
Exercise / conversionBio-Rad A Common Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009749 · form4.xml · nonDerivative · entry 1 Last Andrew J. · CIK 0001485088 · EVP, Chief Operating Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,112.6151 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 8.8470 and 20.7590 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022 and 03/31/2023, respectively. Read SEC document |
| April 29, 2023 Filed May 1, 2023 16:50 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 277 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009748 · form4.xml · derivative · entry 3 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 554 Underlying: Bio-Rad A Common Stock · 277 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 29, 2020, the reporting person was granted 1,384 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 29, 2023 Filed May 1, 2023 16:50 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Tax withholdingBio-Rad A Common Stock | 96 | $450.79 | $43,275.84 |
DisclosureSEC source: 0001062993-23-009748 · form4.xml · nonDerivative · entry 2 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 198.352 Read SEC document |
| April 29, 2023 Filed May 1, 2023 16:50 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
Exercise / conversionBio-Rad A Common Stock | 277 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009748 · form4.xml · nonDerivative · entry 1 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 294.352 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 17.3520 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 03/31/2023. Read SEC document |
| April 08, 2023 Filed Apr 11, 2023 18:39 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Exercise / conversionRestricted Stock Units · Derivative | 700 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009008 · form4.xml · derivative · entry 3 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 700 Underlying: Bio-Rad A Common Stock · 700 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On April 8, 2019, the reporting person was granted 3,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On April 8, 2019, the reporting person was granted 3,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| April 08, 2023 Filed Apr 11, 2023 18:39 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Tax withholdingBio-Rad A Common Stock | 243 | $466.24 | $113,296.32 |
DisclosureSEC source: 0001062993-23-009008 · form4.xml · nonDerivative · entry 2 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,493.268 Read SEC document |
| April 08, 2023 Filed Apr 11, 2023 18:39 UTC |
Daskal IlanEVP, Chief Financial Officer
|
Exercise / conversionBio-Rad A Common Stock | 700 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-009008 · form4.xml · nonDerivative · entry 1 Daskal Ilan · CIK 0001446964 · EVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,736.268 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 44.9320 and 38.3360 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/30/2022 and 3/31/2023, respectively. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 01:00 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 150 | $0.00 Strike: $215.98 | $0.00 |
DisclosureSEC source: 0001062993-23-006320 · form4.xml · derivative · entry 6 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,350 Underlying: Bio-Rad A Common Stock · 150 shares Expires 2027-09-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 01:00 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 850 | $0.00 Strike: $159.32 | $0.00 |
DisclosureSEC source: 0001062993-23-006320 · form4.xml · derivative · entry 5 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 850 shares Expires 2026-09-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option, representing a right to purchase a total of 2,500 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 01:00 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
SaleBio-Rad A Common Stock | 746 | $486.89 | $363,219.94 |
DisclosureSEC source: 0001062993-23-006320 · form4.xml · nonDerivative · entry 4 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,671.3635 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 01:00 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
SaleBio-Rad A Common Stock | 1,000 | $486.08 | $486,080.00 |
DisclosureSEC source: 0001062993-23-006320 · form4.xml · nonDerivative · entry 3 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,417.3635 Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 01:00 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 150 | $215.98 | $32,397.00 |
DisclosureSEC source: 0001062993-23-006320 · form4.xml · nonDerivative · entry 2 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,417.3635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 01:00 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 850 | $159.32 | $135,422.00 |
DisclosureSEC source: 0001062993-23-006320 · form4.xml · nonDerivative · entry 1 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,267.3635 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes 12.1510 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 19:30 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
GrantRestricted Stock Units · Derivative | 644 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-23-003327 · form4.xml · derivative · entry 1 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 644 Underlying: Bio-Rad A Common Stock · 644 shares Expires not disclosed F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F2 · derivative.exercise_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. F2 · derivative.expiration_date: The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 16:52 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionRestricted Stock Units · Derivative | 502 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024047 · form4.xml · derivative · entry 3 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,005 Underlying: Bio-Rad A Common Stock · 502 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F4 · derivative.exercise_date: On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date. F4 · derivative.expiration_date: On December 16, 2019, the reporting person was granted 2,511 restricted stock units, vesting in 5 equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 16:52 UTC |
WRIGHT DARAExecutive Vice President
|
Tax withholdingBio-Rad A Common Stock | 226 | $407.98 | $92,203.48 |
DisclosureSEC source: 0001062993-22-024047 · form4.xml · nonDerivative · entry 2 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,761.9146 Read SEC document |
| December 16, 2022 Filed Dec 19, 2022 16:52 UTC |
WRIGHT DARAExecutive Vice President
|
Exercise / conversionBio-Rad A Common Stock | 502 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-024047 · form4.xml · nonDerivative · entry 1 WRIGHT DARA · CIK 0001796980 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,987.9146 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. F2 · balance_after: Includes 26.0150 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022. Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:33 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
SaleBio-Rad A Common Stock | 0.3809 | $423.61 | $161.35 |
DisclosureSEC source: 0001062993-22-022078 · form4.xml · nonDerivative · entry 3 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:33 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
SaleBio-Rad A Common Stock | 112 | $422.28 | $47,295.36 |
DisclosureSEC source: 0001062993-22-022078 · form4.xml · nonDerivative · entry 2 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0.3809 Read SEC document |
| November 10, 2022 Filed Nov 14, 2022 21:33 UTC |
RAMALINGAM AJITSVP, Chief Accounting Officer
|
SaleBio-Rad A Common Stock | 267 | $421.70 | $112,593.90 |
DisclosureSEC source: 0001062993-22-022078 · form4.xml · nonDerivative · entry 1 RAMALINGAM AJIT · CIK 0001807891 · SVP, Chief Accounting Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112.3809 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $421.47 to $421.94, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F2 · balance_after: Includes 13.884 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 09/30/2022. Read SEC document |
| November 07, 2022 Filed Nov 22, 2022 01:53 UTC |
SCHWARTZ ALICE N10% owner · Director Emeritus
|
GiftBio-Rad B Common Stock | 252 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022604 · form4.xml · nonDerivative · entry 6 SCHWARTZ ALICE N · CIK 0001248076 · 10% owner · Director Emeritus 10b5-1 filing: Not disclosed Ownership: Indirect · By Alice N. Schwartz Revocable Trust Disclosed balance after: 438,146 Read SEC document |
| November 07, 2022 Filed Nov 22, 2022 01:53 UTC |
SCHWARTZ ALICE N10% owner · Director Emeritus
|
GiftBio-Rad A Common Stock | 2,639 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022604 · form4.xml · nonDerivative · entry 1 SCHWARTZ ALICE N · CIK 0001248076 · 10% owner · Director Emeritus 10b5-1 filing: Not disclosed Ownership: Indirect · By Alice N. Schwartz Revocable Trust Disclosed balance after: 1,787,816 Read SEC document |
| November 07, 2022 Filed Nov 28, 2022 19:15 UTC |
Allison SchwartzDirector
|
GiftBio-Rad B Common Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-022795 · form4.xml · nonDerivative · entry 1 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,890 Read SEC document |
| November 07, 2022 Filed Dec 1, 2022 21:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
GiftBio-Rad B Common Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023089 · form4.xml · nonDerivative · entry 3 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 12,900 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| November 07, 2022 Filed Dec 1, 2022 21:35 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
GiftBio-Rad B Common Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023089 · form4.xml · nonDerivative · entry 2 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 331,689 Read SEC document |
| November 07, 2022 Filed Dec 7, 2022 16:07 UTC |
SCHWARTZ STEVEN D10% owner
|
GiftBio-Rad B Common Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023474 · form4.xml · nonDerivative · entry 4 SCHWARTZ STEVEN D · CIK 0000940804 · 10% owner 10b5-1 filing: Not disclosed Ownership: Indirect · By Spouse Disclosed balance after: 12,900 F1 · ownership.nature: The reporting person disclaims beneficial ownership of these shares. Read SEC document |
| November 07, 2022 Filed Dec 7, 2022 16:07 UTC |
SCHWARTZ STEVEN D10% owner
|
GiftBio-Rad B Common Stock | 42 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-023474 · form4.xml · nonDerivative · entry 3 SCHWARTZ STEVEN D · CIK 0000940804 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,128 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionRestricted Stock Units · Derivative | 2,600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · derivative · entry 15 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 2,600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F8 · derivative.exercise_date: On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F8 · derivative.expiration_date: On September 5, 2017, the reporting person was granted 13,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Tax withholdingBio-Rad A Common Stock | 1,575 | $478.32 | $753,354.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 8 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 427,844 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:24 UTC |
SCHWARTZ NORMAN DDirector · Chairman, President, and CEO · 10% owner
|
Exercise / conversionBio-Rad A Common Stock | 2,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019290 · form4.xml · nonDerivative · entry 7 SCHWARTZ NORMAN D · CIK 0000940805 · Director · Chairman, President, and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 429,419 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionRestricted Stock Units · Derivative | 80 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · derivative · entry 12 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 80 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 5, 2017, the reporting person was granted 400 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 5, 2017, the reporting person was granted 400 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Tax withholdingBio-Rad A Common Stock | 33 | $478.32 | $15,784.56 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 8 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,027 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:22 UTC |
Allison SchwartzDirector
|
Exercise / conversionBio-Rad A Common Stock | 80 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019288 · form4.xml · nonDerivative · entry 7 Allison Schwartz · CIK 0001924980 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,060 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · derivative · entry 12 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Tax withholdingBio-Rad A Common Stock | 298 | $478.32 | $142,539.36 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 8 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,550.2754 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:16 UTC |
MAY SIMONEVP, President, LSG
|
Exercise / conversionBio-Rad A Common Stock | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019284 · form4.xml · nonDerivative · entry 7 MAY SIMON · CIK 0001900904 · EVP, President, LSG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,848.2754 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionRestricted Stock Units · Derivative | 500 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · derivative · entry 12 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 500 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 5, 2017, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 5, 2017, the reporting person was granted 2,500 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Tax withholdingBio-Rad A Common Stock | 248 | $478.32 | $118,623.36 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 8 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,405.2125 Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:13 UTC |
ERNST TIMOTHY SEVP, General Counsel & Sec
|
Exercise / conversionBio-Rad A Common Stock | 500 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019280 · form4.xml · nonDerivative · entry 7 ERNST TIMOTHY S · CIK 0001676291 · EVP, General Counsel & Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,653.2125 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Shares of Class A common stock acquired on the vesting of restricted stock units. Read SEC document |
| September 05, 2022 Filed Sep 7, 2022 18:10 UTC |
Dahowski DianeEVP, Global Supply Chain
|
Exercise / conversionRestricted Stock Units · Derivative | 600 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001062993-22-019278 · form4.xml · derivative · entry 12 Dahowski Diane · CIK 0001926636 · EVP, Global Supply Chain 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Bio-Rad A Common Stock · 600 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. F6 · derivative.exercise_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. F6 · derivative.expiration_date: On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.